Should 6-thioguanine nucleotides be monitored in heart transplant recipients given azathioprine?

PubWeight™: 0.87‹?›

🔗 View Article (PMID 8738760)

Published in Ther Drug Monit on June 01, 1996

Authors

E Schütz1, J Gummert, F W Mohr, V W Armstrong, M Oellerich

Author Affiliations

1: Abteilung Klinische Chemie, Georg-August-Univesität Göttingen, Germany.

Articles by these authors

Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation (2003) 3.86

Mediastinitis and cardiac surgery--an updated risk factor analysis in 10,373 consecutive adult patients. Thorac Cardiovasc Surg (2002) 2.81

Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient. Lancet (1993) 2.66

Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial. Circulation (2001) 2.28

Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease. Heart (2004) 2.23

The effect of recombinant human GH replacement therapy on lipoprotein(a) and other lipid parameters in adults with acquired GH deficiency: results of a double-blind and placebo-controlled trial. Eur J Endocrinol (1997) 1.99

The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. Atherosclerosis (1986) 1.85

Stereochemistry of polymerization by DNA-dependent RNA-polymerase from Escherichia coli: an investigation with a diastereomeric ATP-analogue. Proc Natl Acad Sci U S A (1976) 1.65

Intraoperative radiofrequency ablation of chronic atrial fibrillation: a left atrial curative approach by elimination of anatomic "anchor" reentrant circuits. J Cardiovasc Electrophysiol (1999) 1.52

Neuromonitoring and neurocognitive outcome in off-pump versus conventional coronary bypass operation. Ann Thorac Surg (2000) 1.51

Chordal replacement for both minimally invasive and conventional mitral valve surgery using premeasured Gore-Tex loops. Ann Thorac Surg (2000) 1.51

A novel management strategy of steroid-free immunosuppression after liver transplantation: efficacy and safety of tacrolimus and mycophenolate mofetil. Transplantation (2001) 1.51

Population pharmacokinetics of mycophenolic acid in pediatric renal transplant patients using parametric and nonparametric approaches. Pharmacol Res (2010) 1.50

Abdominal aortic aneurysm repair during cardiopulmonary bypass: rationale for a combined approach. Cardiovasc Surg (1997) 1.49

Azathioprine-induced severe pancytopenia due to a homozygous two-point mutation of the thiopurine methyltransferase gene in a patient with juvenile HLA-B27-associated spondylarthritis. Arthritis Rheum (1997) 1.48

Serum Lp(a) concentrations are unaffected by treatment with the HMG-CoA reductase inhibitor Pravastatin: results of a 2-year investigation. Clin Chim Acta (1991) 1.47

Comparison of the antihypertensive efficiency of nitrendipine, metoprolol, mepindolol and enalapril using ambulatory 24-hour blood pressure monitoring. Am J Cardiol (1990) 1.44

Lack of association between raised serum Lp(a) concentration and unsuccessful thrombolysis after acute myocardial infarction. Lancet (1990) 1.41

The use of lidocaine as a test of liver function in liver transplantation. Liver Transpl Surg (1996) 1.39

Median sternotomy for prolonged resuscitation in neonatal tetralogy of Fallot with absent pulmonary valve. J Thorac Cardiovasc Surg (1996) 1.39

Pain is significantly reduced by cryoablation therapy in patients with lateral minithoracotomy. Ann Thorac Surg (2000) 1.39

Total endoscopic computer enhanced coronary artery bypass grafting. Eur J Cardiothorac Surg (2000) 1.39

Comparability of a new turbidimetric digoxin test with other immunochemical tests and with HPLC--a multicenter evaluation. Clin Chem (1997) 1.39

Humoral immune response during coronary artery bypass grafting: A comparison of limited approach, "off-pump" technique, and conventional cardiopulmonary bypass. Circulation (2000) 1.36

Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a). J Lipid Res (1985) 1.33

Helicobacter pylori infection: a risk factor for upper gastrointestinal bleeding after cardiac surgery? Crit Care Med (2000) 1.27

True aneurysm of the superior gluteal artery: case report and review of the literature. J Vasc Surg (1995) 1.25

Echocardiographic monitoring of minimally invasive mitral valve surgery using an endoaortic clamp. J Heart Valve Dis (1996) 1.25

Foreign body in the airway: unusual cause of acute dyspnoe after cardiac surgery. Z Kardiol (2005) 1.23

Pain and quality of life after minimally invasive versus conventional cardiac surgery. Ann Thorac Surg (1999) 1.18

Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion. Ther Drug Monit (2001) 1.17

Identification of glucoside and carboxyl-linked glucuronide conjugates of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil. Br J Pharmacol (1999) 1.16

Developments in robotic cardiac surgery. Curr Opin Cardiol (2000) 1.16

Application of a thermodynamic nearest-neighbor model to estimate nucleic acid stability and optimize probe design: prediction of melting points of multiple mutations of apolipoprotein B-3500 and factor V with a hybridization probe genotyping assay on the LightCycler. Clin Chem (1999) 1.15

Induction of cytokine release by the acyl glucuronide of mycophenolic acid: a link to side effects? Clin Biochem (2000) 1.14

Impact of diabetes mellitus on cardiac surgery outcome. Thorac Cardiovasc Surg (2003) 1.14

Glucuronide and glucoside conjugation of mycophenolic acid by human liver, kidney and intestinal microsomes. Br J Pharmacol (2001) 1.13

ACE-inhibitor treatment attenuates atrial structural remodeling in patients with lone chronic atrial fibrillation. Basic Res Cardiol (2005) 1.11

Twelve-month evaluation of the clinical pharmacokinetics of total and free mycophenolic acid and its glucuronide metabolites in renal allograft recipients on low dose tacrolimus in combination with mycophenolate mofetil. Ther Drug Monit (2003) 1.10

Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor. Klin Wochenschr (1988) 1.09

Structural relationship of an apolipoprotein (a) phenotype (570 kDa) to plasminogen: homologous kringle domains are linked by carbohydrate-rich regions. Biol Chem Hoppe Seyler (1987) 1.08

New approaches to cyclosporine monitoring raise further concerns about analytical techniques. Clin Chem (2000) 1.07

No influence of the MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4-V allele) on dose-adjusted cyclosporin A trough concentrations or rejection incidence in stable renal transplant recipients. Clin Chem (2001) 1.07

Repair of cor triatriatum associated with partially unroofed coronary sinus. Ann Thorac Surg (1999) 1.06

The Leipzig experience with robotic valve surgery. J Card Surg (2001) 1.05

Enzyme immunoassays in clinical chemistry: present status and trends. J Clin Chem Clin Biochem (1980) 1.04

Autopsy findings in patients on postcardiotomy extracorporeal membrane oxygenation (ECMO). Int J Artif Organs (2006) 1.03

Splanchnic oxygen transport, hepatic function and gastrointestinal barrier after normothermic cardiopulmonary bypass. Acta Anaesthesiol Scand (2004) 1.02

Therapeutic monitoring of mycophenolic acid. A consensus panel report. Clin Biochem (1998) 1.01

Robot-assisted minimally invasive solo mitral valve operation. J Thorac Cardiovasc Surg (1998) 1.01

Enhanced procoagulatory activity (PCA) of human monocytes/macrophages after in vitro stimulation with chemically modified LDL. Atherosclerosis (1989) 1.01

Pharmacokinetic and metabolic investigations of mycophenolic acid in pediatric patients after renal transplantation: implications for therapeutic drug monitoring. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients. Ther Drug Monit (2000) 1.01

Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin-induced extracorporeal LDL precipitation (HELP). Eur J Clin Invest (1989) 1.00

Total endoscopic off-pump coronary artery bypass grafting. Heart Surg Forum (2000) 1.00

The reaction between thiols and 8-azidoadenosine derivatives. Nucleic Acids Res (1976) 1.00

Prospectively randomized evaluation of stentless versus conventional biological aortic valves: impact on early regression of left ventricular hypertrophy. Circulation (1999) 1.00

Quality of computer enhanced totally endoscopic coronary bypass graft anastomosis--comparison to conventional technique. Eur J Cardiothorac Surg (1999) 0.99

Simultaneous determination of mycophenolic acid and its glucuronide in human plasma using a simple high-performance liquid chromatography procedure. Clin Chem (1998) 0.98

Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid. Clin Chim Acta (1991) 0.98

Nocturnal asthma: effect of a once per evening dose of sustained release theophylline. Eur J Respir Dis (1985) 0.98

Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in pediatric and adult renal transplant recipients. German Study group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients. J Am Soc Nephrol (1998) 0.98

Minimally invasive saphenous vein harvesting techniques: morphology and postoperative outcome. Ann Thorac Surg (2000) 0.97

Epicardial treatment of atrial fibrillation using cryoablation in an acute off-pump sheep model. Thorac Cardiovasc Surg (2003) 0.97

Significance of arterial ketone body ratio measurement in human liver transplantation. Transplantation (1990) 0.97

Comparison of low molecular weight heparin to standard heparin in hemodialysis/hemofiltration. Kidney Int (1988) 0.97

Extracardiac conduit fontan procedure: early and intermediate results. Eur J Cardiothorac Surg (2000) 0.97

Resection of a right atrial metastatic melanoma with unknown origin of primary tumor. Eur J Cardiothorac Surg (1999) 0.96

Cyclosporin whole blood immunoassays (AxSYM, CEDIA, and Emit): a critical overview of performance characteristics and comparison with HPLC. Clin Chem (1998) 0.96

Dynamic annuloplasty for mitral regurgitation. J Thorac Cardiovasc Surg (2012) 0.96

Determination of methotrexate in serum by a rapid, fully mechanized enzyme immunoassay (EMIT). J Clin Chem Clin Biochem (1980) 0.96

Therapeutic drug monitoring of mycophenolic acid: comparison of HPLC and immunoassay reveals new MPA metabolites. Transplant Proc (1998) 0.96

Urgency of operation in infracardiac total anomalous pulmonary venous connection. Ann Thorac Surg (2000) 0.95

Minimally invasive approach for redo mitral valve surgery: a true benefit for the patient. J Card Surg (2002) 0.95

DNA base bulge vs unmatched end formation in probe-based diagnostic insertion/deletion genotyping: genotyping the UGT1A1 (TA)(n) polymorphism by real-time fluorescence PCR. Clin Chem (2000) 0.95

Induction of inducible nitric oxide synthase is an essential part of tumor necrosis factor-alpha-induced apoptosis in MCF-7 and other epithelial tumor cells. Lab Invest (1999) 0.95

The German Aortic Valve Registry (GARY): a nationwide registry for patients undergoing invasive therapy for severe aortic valve stenosis. Thorac Cardiovasc Surg (2012) 0.95

Determination of the acyl glucuronide metabolite of mycophenolic acid in human plasma by HPLC and Emit. Clin Chem (2000) 0.94

New developments in the immunosuppressive drug monitoring of cyclosporine, tacrolimus, and azathioprine. Clin Biochem (2001) 0.94

Rapid detection of prothrombotic mutations of prothrombin (G20210A), factor V (G1691A), and methylenetetrahydrofolate reductase (C677T) by real-time fluorescence PCR with the LightCycler. Clin Chem (1999) 0.94

Increased mycophenolic acid exposure in stable kidney transplant recipients on tacrolimus as compared with those on sirolimus: implications for pharmacokinetics. Clin Pharmacol Ther (2009) 0.94

Therapeutic drug monitoring of cyclosporine and tacrolimus. Update on Lake Louise Consensus Conference on cyclosporin and tacrolimus. Clin Biochem (1998) 0.94

The MEGX test: a tool for the real-time assessment of hepatic function. Ther Drug Monit (2001) 0.94